SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
From the Blogosphere
Trading Radar for 10/19: Apple (AAPL), Texas Instruments (TXN), Boston Scientific (BSX), Steel Dynamics (STLD), A. Schulman (SHLM) Reports
|
The Trading Radar highlights key earnings and economic announcements for tomorrow's trading session:<u>Before Market Opens:</u>Earnings:A Schulman (NASDAQ: SHLM) – consensus EPS $0.16BB&T Corporation (NYSE: BBT) – consensus EPS $0.22Gannett (NYSE: GCI) – consensus EPS $0.41McMoRan Exploration Co. (NYSE: MMR) – consensus loss $0.56RLI Corp. (NYSE: RLI) – consensus EPS $0.94<u>Intraday or Not Specified:</u>Earnings:Acxiom (NASDAQ: ACXM) – consensus EPS $0.11Brown & Brown (NYSE: BRO) – consensus EPS $0.29Great Atlantic & Pacific Tea (NYSE: GAP) – consensus loss $0.84Hasbro (NYSE: HAB) – consen...
|
Fund Performance Period 9
Morning Movers 9/8: OPXA, ITLN, CBY, GTN, HLCS, ORH, CHP Higher; OSIR, CHIP, SPPI, AIG Lower
Opexa Therapeutics, Inc. (NASDAQ: OPXA) <font>77% HIGHER;</font> announced results from further analysis of the double-blind, placebo-controlled, 52-week Phase IIb TERMS clinical study of 150 patients with Relapsing Remitting MS (RRMS). This analysis evaluated patients with an annualized relapse rate of one or greater at study entry (ARR>=1). More than 83% of the Tovaxin-treated group (n=85) remained relapse free at one year and the annualized relapse rate after treatment decreased to 0.20, a 42% reduction compared to placebo. Here is our full report.Intellon Corporation (NASDAQ: ITLN) <fon...
|
Unusual 11 Mid-Day Movers 9/8: OPXA, ITLN, CBY, ORH Higher; OSIR, UBSH, EXXI, SPPI Lower
Opexa Therapeutics, Inc. (NASDAQ: OPXA) <font>217% HIGHER;</font> announced results from further analysis of the double-blind, placebo-controlled, 52-week Phase IIb TERMS clinical study of 150 patients with Relapsing Remitting MS. This analysis evaluated patients with an annualized relapse rate of one or greater at study entry (ARR>=1). More than 83% of the Tovaxin-treated group (n=85) remained relapse free at one year and the annualized relapse rate after treatment decreased to 0.20, a 42% reduction compared to placebo. Here is our full report.Intellon Corporation (NASDAQ: ITLN) <font>41.8...
|
Bookkeeping: Weekly Changes to Fund Positions Year 3, Week 6
|
|
|
Year 3, Week 6 Major Position Changes
<>To see historic weekly fund changes click here OR the label at the bottom of this entry entitled 'fund positions'.
Cash: 68.4% (v 72.5% last week) 24 long bias: 16.7% (v 14.1% last week) 9 short bias: 14.9% (v 13.5% last week) *includes long term puts
33 positions (vs 31 last week)
Weekly thoughts A short but very positive week with 3 very strong days, including a "double top" breakout on Thursday, followed by essentially no pullback on Friday. At this point it seems a market driven on technicals (the charts say to buy, so I must buy), performance anxiety by>...
|
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
| StreetInsider.com on ATHR |
Visit streetinsider.com
Be the first to start a discussion and earn 2 points.
More Resources
|